SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) Commences Phase 2 Study of HerpV Vaccine for the Treatment of Genital Herpes
Your Message